Human atrial living myocardial slices provide a viable in vitro model for studying atrial pathophysiology and biomechanics across different disease states.
Atrial dysfunction plays a critical role in cardiac disease, particularly during arrhythmias and in heart failure, where impaired atrial contraction can compromise cardiac output. Yet, models that allow direct assessment of human atrial biomechanics remain scarce. Living myocardial slices (LMS) have the potential to revolutionize preclinical cardiac studies by preserving native architecture and performance in near-physiological environments, offering a patient-specific platform to investigate atrial function. To address this gap, we present the first functional analysis of human atrial LMS across diverse disease phenotypes, including healthy tissue, heart failure, rhythm disorders and cardiac dilatation. Using the largest human atrial LMS dataset to date, containing 250 slices from 48 patients, we assessed contractile force, kinetics, force-frequency relationships, and refractoriness during the acute culture phase. Atrial slices exhibited faster contractions than ventricular counterparts. HF and dilated atria showed reduced contractile force and prolonged contraction and relaxation, whereas slices from patients with atrial fibrillation displayed preserved or enhanced kinetics with increased variability in refractoriness. Structural analyses confirmed elevated fibrosis in all disease groups, along with disease-specific alterations in cellular morphology and tissue organization. Together, these findings provide a reference framework for human atrial biomechanics, thereby positioning LMS as a promising model for studying atrial pathophysiology in vitro.
Doorn et al. (Thu,) studied this question.